STERIS plc
STE
Κατάταξη σε μετοχές
#1074
STERIS plc provides infection prevention products and services in the United... STERIS plc provides infection prevention products and services in the United States, Ireland, and internationally. It operates through three segments: Healthcare, Applied Sterilization Technologies, and Life Sciences. The company offers cleaning chemistries and sterility assurance products, automated endoscope reprocessing system and tracking products, endoscopy accessories, instruments, washers, and sterilizers and other pieces of capital equipment, as well as equipment used directly in the procedure rooms, including surgical tables, lights, equipment management services, and connectivity solutions; and various preventive maintenance programs, repair services, custom process improvement consulting, and outsourced instrument sterile processing, as well as instrument, devices, and endoscope repair and maintenance services. It also provides process controls and monitoring systems, as well as integrated sterilization equipment, such as accelerators, product handling, and automation; and sterilization modalities, product development, materials testing, and process validation, as well as support services for sterilization equipment and control systems comprising installation, preventive maintenance, updates, repairs, and troubleshooting. In addition, the company offers pharmaceutical detergents, cleanroom disinfectants and sterilants, pharmaceutical grade and research sterilizers and washers, sterility assurance and maintenance products, vaporized hydrogen peroxide room decontamination systems and sterilizers, and high purity water and pure steam generators; and preventive maintenance programs and repair services to support the operation of capital equipment. It serves healthcare providers, medical device and pharmaceutical manufacturers, biopharmaceutical manufacturing facilities, and hospitals. The company was formerly known as New STERIS Limited and changed its name to STERIS plc in November 2015. STERIS plc was founded in 1985 and is headquartered in Mentor, Ohio.
Τιμή μετοχής
$222.18
Τελευταίος συγχρονισμός: 2026-10-16
Κεφαλαιοποίηση
$21.66B
Αλλαγή (1 ημέρα)
-0.65%
Αλλαγή (1 έτος)
-7.51%
Χώρα
IE
Εμπόριο STERIS plc (STE)
Κατηγορία
Healthcare
Λειτουργικό Περιθώριο για STERIS plc (STE)
Λειτουργικό Περιθώριο στις October 2026 TTM: 18.91%
Σύμφωνα με τις τελευταίες οικονομικές αναφορές και την τιμή μετοχής της STERIS plc, το τρέχον Λειτουργικό Περιθώριο (TTM) είναι 18.91%. Στο τέλος του 2024, το Λειτουργικό Περιθώριο ήταν 16.27%.
Ιστορικό Λειτουργικού Περιθωρίου για την STERIS plc από 2000 έως 2026
Λειτουργικό Περιθώριο στο τέλος κάθε έτους
| Έτος | Λειτουργικό Περιθώριο | Αλλαγή |
|---|---|---|
| 2026 (TTM) | 18.91% | 19.16% |
| 2025 | 15.87% | -2.46% |
| 2024 | 16.27% | -6.71% |
| 2023 | 17.44% | 54.20% |
| 2022 | 11.31% | -35.92% |
| 2021 | 17.65% | -0.40% |
| 2020 | 17.72% | 19.97% |
| 2019 | 14.77% | -3.21% |
| 2018 | 15.26% | 76.21% |
| 2017 | 8.66% | -8.94% |
| 2016 | 9.51% | -22.56% |
| 2015 | 12.28% | -3.69% |
| 2014 | 12.75% | -21.15% |
| 2013 | 16.17% | 2.34% |
| 2012 | 15.80% | 123.80% |
| 2011 | 7.06% | -56.42% |
| 2010 | 16.20% | 19.91% |
| 2009 | 13.51% | 38.28% |
| 2008 | 9.77% | -15.04% |
| 2007 | 11.50% | 21.69% |
| 2006 | 9.45% | -27.70% |
| 2005 | 13.07% | 4.73% |
| 2004 | 12.48% | -3.55% |
| 2003 | 12.94% | 39.14% |
| 2002 | 9.30% | 207.95% |
| 2001 | 3.02% | -22.76% |
| 2000 | 3.91% | 0.00% |
Λειτουργικό Περιθώριο για παρόμοιες εταιρείες ή ανταγωνιστές
| Εταιρεία | Λειτουργικό Περιθώριο | Διαφορά Λειτουργικού Περιθωρίου | Χώρα |
|---|---|---|---|
| 0.00% | - |
CN
|
|
| 0.00% | - |
CH
|
|
| 0.00% | - |
CH
|
|
| 0.00% | - |
CN
|
|
| 12.88% | -99.32% |
KR
|
Τι είναι το Λειτουργικό Περιθώριο μιας εταιρείας;
Το Λειτουργικό Περιθώριο είναι ένας βασικός δείκτης για την αξιολόγηση της κερδοφορίας μιας εταιρείας. Όσο υψηλότερο είναι το Operating Margin, τόσο το καλύτερο, καθώς δείχνει ότι η εταιρεία πωλεί τα προϊόντα ή τις υπηρεσίες της με σημαντικό περιθώριο κέρδους. Υπολογίζεται διαιρώντας τα κέρδη της εταιρείας με τα έσοδά της.